Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gland Pharma Limited Call Transcript 2026

Apr 21, 2026

59319_rns_2026-04-21_90e6243f-6d17-4485-922b-0bbe9090bdf1.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

April 21, 2026

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245

National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol: GLAND (ISIN: INE068V01023)

Dear Sir/Madam,

Sub: Earnings Conference Call

We hereby inform you that the Earnings Call for Investors/Analysts will be held on Friday , May 15, 2026 at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the quarter and financial year ended March 31, 2026.

The details of the Earnings Call for Investors/Analysts are enclosed.

The transcript and the audio recording of the Earnings Call will be made available on the Company’s website.

This is for your information and records.

Yours truly, For Gland Pharma Limited Digitally signed by Pallerlamudi Pallerlamudi Sampath KumarDN: cn=Pallerlamudi Sampath Kumar, c=IN, o=Personal, Sampath Kumar email=[email protected] Date: 2026.04.21 16:22:10 +05'30' Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer

Encl: As above

==> picture [580 x 78] intentionally omitted <==

==> picture [69 x 51] intentionally omitted <==

EARNINGS CONFERENCE CALL FOR Q4 FY26

The Company will host an earnings conference call for the Q4 FY26 on May 15, 2026, at 18:30 hours (IST) . During the call, the management team will discuss the performance and take questions related to the business. The audio recording and transcript of the conference call will be available after the call on the company’s website at www.glandpharma.com.

Earnings Conference Dial-In InformationEarnings Conference Dial-In Information Earnings Conference Dial-In InformationEarnings Conference Dial-In Information
Diamondpass linkDiamond pass link Click**here** to register**Click **_here _to register
Universal AccessUniversal Access +91 22 6280 1516+91 22 7115 8875+91 22 6280 1516+91 22 7115 8875
International Toll-Free NumberInternational Toll-Free Number USA – 18667462133UK – 08081011573Singapore – 8001012045HongKong– 800964448USA -18667462133UK -08081011573Singapore - 8001012045Hong Kong - 800964448

Contact: Sampath Kumar Pallerlamudi Shriniwas Pradeep Dange Company Secretary and Compliance Officer Investor Relations [email protected]